<DOC>
	<DOC>NCT00256919</DOC>
	<brief_summary>This study is designed to compare a range of doses of GW856553 versus placebo on the biomarkers associated with rheumatoid arthritis</brief_summary>
	<brief_title>Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Inclusion criteria: Must have a diagnosis of RA according to the revised 1987 criteria of the American College of Rheumatology. Must have 3 or more swollen or 3 or more tender/painful joints at screening. Must be on stable weekly methotrexate (2.5mg25mg) for at least eight weeks prior to screening. Exclusion criteria: Must not be morbidly obese.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>GW856553</keyword>
	<keyword>biomarkers</keyword>
	<keyword>CRP</keyword>
	<keyword>rheumatoid arthritis</keyword>
</DOC>